Supplier Verification in India: The Complete Guide
India is Africa's pharmacy and one of its biggest sources of textiles, machinery, auto parts and agro-inputs. It is also — helpfully — one of the most verifiable sourcing markets on earth: India's public registries expose more company data for free than almost any other manufacturing country. The problem is that most buyers do not know the registries exist, or what a healthy record looks like.
This guide teaches you to verify an Indian supplier the way a due-diligence professional would: reading MCA records and CINs, validating GSTINs, checking export credentials via the IEC, interpreting Udyam registrations, matching the bank account to the registered entity, and layering sector-specific checks for pharmaceuticals — where verification is not just about fraud, but about safety and regulatory admissibility of the goods themselves.
On this page
India's verification landscape: what exists and what it tells you
Four public identifiers do most of the work. The CIN (Corporate Identity Number) is a 21-character code assigned by the Ministry of Corporate Affairs to every registered company — it encodes listing status, industry, state, year of incorporation and registration number, and unlocks the MCA master data record: status (active/struck off), directors, registered office, authorised and paid-up capital, and filing history.
The GSTIN (Goods and Services Tax Identification Number) is a 15-character tax identifier that validates against the public GST portal, showing the legal name, trade name, state, registration date and taxpayer status. A supplier invoicing you without a valid, active GSTIN either is not real, is not the entity they claim, or is operating outside the tax system — all disqualifying.
The IEC (Importer-Exporter Code) issued by the DGFT is mandatory for any Indian entity exporting goods. No IEC, no legal export — a "manufacturer-exporter" who cannot produce one is neither. Finally, Udyam registration identifies MSMEs; useful context for judging scale claims: a "500-worker factory" registered as a micro enterprise is telling you something.
Partnerships and proprietorships — common in textiles and trading — do not appear in MCA, which covers companies and LLPs. For these, GSTIN + IEC + bank account-name matching carry the verification weight, supplemented by Udyam and, where stakes justify it, a site visit or third-party audit.
Reading the record: healthy vs suspicious profiles
A healthy exporter profile is coherent: an active MCA status with several years of history; a business scope (main object clause) matching the goods offered; directors who do not each sit on dozens of shell entities; a GSTIN in the same state as the claimed factory; an IEC of similar vintage to the export claims; and — the golden check — a bank account in exactly the registered legal name.
Suspicious profiles are incoherent: a company incorporated eight months ago claiming a decade of export history; paid-up capital of ₹100,000 behind claims of massive production capacity; a registered office that is a residential flat in a different state from the "factory"; a trade name that keeps shifting between quotes, invoices and the requested beneficiary account; or a request to pay a director's personal account or an unrelated third company "for faster processing".
The account-name check deserves emphasis because it defeats the dominant fraud pattern. Legitimate Indian exporters invoice and receive funds in their registered legal name (or a properly documented registered trade name). Any mismatch between the verified entity and the beneficiary account is a stop signal — not a negotiation point.
Pharma-specific due diligence: verification is safety
For pharmaceutical imports — Africa's largest India-sourced category — verification extends beyond corporate existence into regulatory standing, because the risk is not only losing money but importing substandard or unregistered product. Layer these checks: WHO GMP certification for the manufacturing site (not just the company); state drug licences; product-level registrations in your destination market (Ghana FDA, NAFDAC in Nigeria, PPB in Kenya); and whether the supplier is a manufacturer or a merchant exporter reselling another site's product.
Merchant exporters are legitimate and common, but you must know whose factory actually makes the product, because your destination regulator will ask — product registration dossiers reference the manufacturing site. A merchant exporter who will not disclose the manufacturer is offering you an unregisterable product.
Batch-level discipline completes the picture: certificates of analysis (CoA) per batch, agreed shelf-life-remaining minimums at shipment, and inspection rights. Structure payment so the balance releases against documents including the CoA — this aligns the money flow with the quality gate.
Step-by-step process
Collect the identifiers upfront
Before any negotiation: legal entity name, CIN (for companies/LLPs), GSTIN, IEC, Udyam number if MSME, factory address, and the exact beneficiary bank account name. Legitimate exporters share all of this without friction.
Pull the MCA master data
Verify status is active, incorporation date fits the history claimed, main object covers the goods, directors are plausible, and the registered office is consistent with the operation described.
Validate GSTIN and IEC
Confirm the GSTIN is active and the legal name matches MCA; confirm the IEC exists and belongs to the same entity. Mismatched names across identifiers is the classic shell-game tell.
Match the money to the entity
Beneficiary account name must exactly match the registered legal name. Personal accounts, sister companies and "processing agents" are stop signals, not conveniences.
Layer sector checks
Pharma: WHO GMP, drug licences, destination-market product registration, manufacturer disclosure. Textiles/machinery: factory evidence, export references to your region, inspection agency familiarity.
Screen and document
Fraud blacklists, litigation, sanctions exposure. Compress the registry work with a Verify AI check (under a minute, documented report) and file it with the order.
Structure payment to match verified risk
Verified + established: 30% deposit, 70% against documents. Verified + new: escrow-style release on the balance. Unverifiable on any core check: do not pay at all.
Payment options compared
| Method | Best for | What to know |
|---|---|---|
| INR via RTGS (large value) | Invoices in rupees; large orders | Supplier receives INR in their own account in 24–48h; removes their conversion cost and often improves pricing. RTGS handles large-value transfers. |
| INR via NEFT | Standard-size INR invoices | 24–72h settlement; the everyday rail for mid-size payments into India. |
| USD wire | USD-denominated contracts | 1–3 business days via correspondents; Indian exporters handle USD receipts routinely under FEMA. Agree who bears correspondent deductions. |
| Escrow-style document release | First orders; pharma; high-value custom goods | Balance held and released against B/L + CoA/inspection certificate. Aligns the payment gate with the quality gate — the structure this guide recommends for new relationships. |
FX considerations
Paying India from Africa crosses GHS/NGN/KES→INR, usually bridged through dollar liquidity. INR settlement (RTGS/NEFT) frequently earns better supplier pricing than USD invoicing — the exporter avoids conversion and FEMA paperwork friction on their side — so ask for dual quotes and compare the all-in locked cost per route.
Both legs can move between pro-forma and balance payment, so lock the executable rate at commitment. KeyBS Pay pricing is from 1.5%, route-dependent, confirmed on the quote — with the receive amount fixed so the supplier's INR expectation and your cost cannot drift apart.
Tip: Pharma invoices are often USD-denominated by convention even when INR settlement is available — asking "what is your price for INR settlement?" is free and regularly worth 1–2%.
Supplier verification workflow
MCA/CIN: active status, incorporation date vs history claimed, main object covers the goods, plausible directors, consistent registered office.
GSTIN: live-portal validation — active status, legal name matching MCA, state matching the claimed factory location.
IEC: exists, active, and registered to the same legal entity — mandatory for any genuine exporter.
Account-name match + screening: beneficiary account exactly matches the registered name; fraud blacklists, litigation and sanctions screened; report documented and filed. Verify AI runs this stack in under a minute.
Trade escrow guidance
Escrow-style release is the natural companion to verification for India orders: verification tells you the counterparty is real; document-released payment ensures even a real counterparty only gets fully paid when goods provably ship to spec. For pharma, tie release to the bill of lading plus batch CoA; for textiles and machinery, B/L plus third-party inspection certificate.
The structure is simple to propose and widely accepted by serious Indian exporters: 30% deposit to schedule production, 70% funded into escrow before ex-factory, released on documents. Model the cost with the escrow fee calculator — it is quote-based by corridor and order size.
Country regulations to know
FEMA & export documentation
India's Foreign Exchange Management Act governs export receipts; legitimate exporters are practised at compliant USD/INR receipt against shipping documents. A supplier proposing informal payment channels is proposing to violate their own regulator first — and yours second.
GST on exports
Exports from India are zero-rated: you should not be charged Indian GST on export invoices. GST appearing on your invoice signals either error or a domestic-only supplier improvising.
Pharma regulatory stack
CDSCO and state drug licences on the India side; your destination regulator (FDA Ghana, NAFDAC, PPB, SAHPRA) on yours. Product registration references the manufacturing site — verify the site, not just the seller.
Destination conformity
Standard destination rules apply to other categories — SONCAP for Nigeria, GSA regime for Ghana, PVoC for Kenya. Indian exporters familiar with African lanes know these programmes; their fluency is itself a verification signal.
Regulatory summaries are for orientation only and change over time — confirm current requirements with your clearing agent, bank or counsel.
Worked cost example
Worked example: a Nairobi pharmaceutical distributor orders USD 40,000 of generic medicines CIF Mombasa from a verified Gujarat manufacturer (pharma often quotes CIF; duty on medicines is frequently low or zero — illustrative).
| Goods value (CIF Mombasa, incl. freight & insurance) | USD 40,000 |
| Import duty (medicines — often 0%) | USD 0 |
| VAT/levies (category-dependent; many medicines exempt) | USD 0–2,000 |
| PPB registration & import permit costs (amortised) | USD 600 |
| Clearing & port charges (est.) | USD 700 |
| Verification + inspection (Verify AI + batch CoA review) | USD 350 |
| Payment costs (from 1.5%, route-dependent) | USD 600+ |
| Estimated total landed cost | ≈ USD 42,300–44,300 |
Illustrative planning figures — pharma duty/VAT treatment varies sharply by product schedule and country. The verification line is the cheapest row on the table and removes the largest risk.
Settlement & delivery timeline
Common mistakes to avoid
Verifying the brand, paying someone else
The quote says one name, the invoice a second, the beneficiary account a third. Every name in the chain — quote, invoice, registry record, bank account — must reconcile to one verified entity.
Treating a GST certificate PDF as proof
Certificates are images; registries are truth. Validate the GSTIN against the live portal and the CIN against MCA rather than trusting attachments, which are trivially forged.
Skipping manufacturer disclosure on pharma
Buying from a merchant exporter without knowing the manufacturing site leaves you with product your regulator may never register. Site and product registrations must line up before money moves.
Confusing Udyam/MSME status with capability
MSME registration is a size classification, not a quality mark. Use it to sanity-check scale claims, not as a substitute for factory evidence.
Paying 100% upfront because "it's a small order"
Small orders are exactly how bad counterparties harvest deposits at scale. The 30/70 document-released structure costs nothing to ask for and filters unserious suppliers instantly.
Ignoring the partnership/proprietorship gap
No MCA record is expected for proprietorships — but that makes GSTIN, IEC, account-name match and physical evidence carry the full weight. Absence from MCA is not a red flag; skipping the remaining checks is.
Your checklist
- 1Collect legal name, CIN, GSTIN, IEC, Udyam (if MSME), factory address and beneficiary account name before negotiating
- 2Verify MCA master data: active status, incorporation date, object clause, directors, registered office
- 3Validate GSTIN on the live portal; confirm legal name and state match
- 4Confirm the IEC exists and belongs to the same entity
- 5Match the beneficiary bank account exactly to the registered legal name
- 6Pharma: verify WHO GMP for the manufacturing site, drug licences, and destination product registration; demand manufacturer disclosure from merchant exporters
- 7Screen fraud blacklists, litigation and sanctions; file the documented verification report
- 8Request dual pricing (USD vs INR settlement) and compare all-in locked costs
- 9Structure 30% deposit / 70% document-released or escrow; tie release documents to your quality gate (CoA/inspection)
- 10Lock FX on both legs at commitment via a quote
- 11Keep invoice, payment and customs values consistent for destination clearing
- 12Re-verify annually and before any change in beneficiary account details
Frequently asked questions
How do I verify an Indian company for free?
MCA master data (via the CIN or company name) shows status, directors and capital; the GST portal validates GSTINs; DGFT confirms IECs; Udyam confirms MSME registrations. The friction is knowing where to look and reconciling names across them — which is what a registry-backed check like Verify AI automates in under a minute.
What is a CIN and what does it tell me?
The Corporate Identity Number is a 21-character MCA identifier encoding listing status, industry, state, incorporation year and registration number. It unlocks the company's master record: active/struck-off status, directors, registered office and filing history — the skeleton of any India verification.
My supplier is a proprietorship with no MCA record. Is that a red flag?
No — proprietorships and partnerships (common in textiles and trading) are not registered with MCA. Verification weight shifts to GSTIN validation, IEC confirmation, exact account-name matching, Udyam registration and physical evidence. Absence from MCA is expected; skipping the remaining checks is the mistake.
What is the single most important check before paying?
The account-name match: the beneficiary bank account must exactly match the verified registered entity. It defeats the dominant fraud pattern — a real company's identity wrapped around a diverted payment — and it costs nothing to enforce.
How do I verify an Indian pharmaceutical supplier specifically?
Corporate checks first (MCA, GSTIN, IEC), then the regulatory layer: WHO GMP certification for the actual manufacturing site, state drug licences, and product registration in your destination market (FDA Ghana, NAFDAC, PPB, SAHPRA). Merchant exporters must disclose the manufacturer — the dossier your regulator holds references the site.
Should I pay Indian suppliers in USD or INR?
INR settlement (RTGS for large value, NEFT otherwise) frequently earns 1–2% better pricing because the exporter avoids conversion cost and paperwork friction. USD suits USD-denominated contracts. Ask for dual quotes and compare the all-in locked cost — then lock the rate at commitment either way.
What payment structure should I use with a newly verified supplier?
30% deposit to schedule production, 70% held in escrow-style release against the bill of lading plus your quality document (CoA for pharma, inspection certificate for goods). Verification proves the counterparty exists; document release ensures they only get fully paid when goods provably ship to spec.
What are the biggest red flags with Indian suppliers?
Names that shift between quote, invoice and beneficiary account; certificates offered as PDFs but failing live-registry validation; incorporation dates that contradict history claims; personal accounts "for faster processing"; pharma sellers refusing manufacturer disclosure; and prices dramatically below the market for branded-equivalent goods.
How long does proper verification take?
The registry stack (MCA + GSTIN + IEC + screening + account match) runs in under a minute with an automated check, or a few hours manually. Pharma regulatory cross-checks add days because destination registrations must be confirmed. Either way it is days, not weeks — and always shorter than recovering a diverted payment, which is usually never.
Are Indian export scams common?
The overwhelming majority of Indian exporters are legitimate — the ecosystem is large, mature and well-regulated. But the corridor's scale attracts fraud at the margins, concentrated on unverifiable counterparties and diverted-account patterns. The checks in this guide filter nearly all of it for a trivial cost.
What is an IEC and why does it matter?
The Importer-Exporter Code from DGFT is mandatory for any Indian entity exporting goods — no IEC, no legal export. A "manufacturer-exporter" who cannot produce an IEC in the same legal name you verified is not an exporter, whatever the website says.
Can KeyBS Pay verify the supplier and handle the payment together?
Yes — that is the designed workflow: Verify AI runs the registry-backed verification with a documented report, the quote locks your executable FX rate on both legs, and the balance can be structured as document-released or escrow-style so the payment gate matches the quality gate.
Keep going
Industry playbooks
More guides
Compare providers
Verify before a single rupee moves
Registry-backed Indian supplier verification in under a minute — then lock your rate and structure the balance against documents.